USDJPY – 1-Minute Chart – 230126Japanese Inflation and PMI Numbers Support a Hawkish BoJ Policy Stance Ahead of the monetary policy decision, Japanese economic
Latest News
In the case of the Federal Reserve, Supreme Court appears to carve out a murky exception
WASHINGTON (AP) — The Supreme Court for the past year has repeatedly allowed President Donald Trump to fire heads of independent agencies, but it
Cathie Wood Loads Up On This Robotaxi Stock, Ark Dumps Roku In Latest Trades
On Thursday, Cathie Wood-led Ark Invest made significant trades involving Tempus AI Inc. (NASDAQ:TEM), WeRide Inc. (NASDAQ:WRD), and Roku Inc. (NASDAQ:ROKU). The Tempus AI Trade Ark Invest’s interest in Tempus AI was evident as
Gold, silver ETFs rise up to 30% from Thursday's lows as record precious metal rally extends: Should you buy here?
The ETFs however are still away from their 52-week highs, which they had hit a day before yesterday before taking a breather from the
Trump claims Federal Reserve has been 'discredited' under Powell's leadership
President Donald Trump slammed Federal Reserve Chairman Jerome Powell again Thursday night, claiming that the reserve has been discredited after he kept U.S. interest
Understanding metal-based ETFs before you invest
For generations, Indian households have maintained a consistent relationship with gold and silver in their physical forms. Traditionally, the purchase of jewellery or coins
Trump pushes for 10% cap on credit card interest rates
WASHINGTON, D.C. – On January 9, President Donald Trump announced that he wanted banks to cap the interest rates on their credit cards at
The S&P 500 Hasn't Been This Expensive Since the Early 2000s. Is a Crash Inevitable in 2026?
The Shiller P/E ratio is nearly at 41, and it’s the highest it’s been since before the dot-com crash. In the past three years,
Is Nvidia the Most Capital-Efficient Stock to Invest in?
Nvidia’s NVDA aggressive expansion in AI infrastructure, data centers, and advanced semiconductor manufacturing is a reason that investors and analysts will want to watch its
Stock Market Today, Jan. 20: Corvus Pharmaceuticals Surges After Positive Phase 1 Eczema Drug Data
Early eczema trial success and heavy trading are rapidly reshaping how investors view this drug developer, today, Jan. 20, 2026.